Clinical Trial Update: Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the efficacy and safety of cannabidiol for gastroparesis and functional dyspepsia; results completed with posted results in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Gastroparesis

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Mayo Clinic | Conditions: Gastroparesis, Dyspepsia | Phase 2 | Status: COMPLETED | Results posted: 2024-02-13